CID 56948249

Deleobuvir

Structural Information

Molecular Formula
C34H33BrN6O3
SMILES
CN1C2=C(C=CC(=C2)C(=O)NC3(CCC3)C4=NC5=C(N4C)C=C(C=C5)/C=C/C(=O)O)C(=C1C6=NC=C(C=N6)Br)C7CCCC7
InChI
InChI=1S/C34H33BrN6O3/c1-40-26-17-22(10-11-24(26)29(21-6-3-4-7-21)30(40)31-36-18-23(35)19-37-31)32(44)39-34(14-5-15-34)33-38-25-12-8-20(9-13-28(42)43)16-27(25)41(33)2/h8-13,16-19,21H,3-7,14-15H2,1-2H3,(H,39,44)(H,42,43)/b13-9+
InChIKey
BMAIGAHXAJEULY-UKTHLTGXSA-N
Compound name
(E)-3-[2-[1-[[2-(5-bromopyrimidin-2-yl)-3-cyclopentyl-1-methylindole-6-carbonyl]amino]cyclobutyl]-3-methylbenzimidazol-5-yl]prop-2-enoic acid
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

18
References

708
Patents

652.17975 Da
Monoisotopic Mass

5.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 653.18703 253.7
[M+Na]+ 675.16897 253.8
[M+NH4]+ 670.21357 252.3
[M+K]+ 691.14291 256.2
[M-H]- 651.17247 255.1
[M+Na-2H]- 673.15442 253.5
[M]+ 652.17920 252.1
[M]- 652.18030 252.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe